The global clinical microbiology market size was valued at USD 12.42 billion in 2020 and is projected to expand at a substantial CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to the constant increasing occurrences of infectious diseases and chronic illness.
Clinical microbiology is a medical discipline that includes a wide range of methodologies, which are primarily focused on finding solutions in terms of isolating, identifying, and monitoring microorganisms. For various treatment process of chronic illness and infectious, researchers and scientists have largely depended on to study microorganisms for treatment purposes and clinical microbiology is a key aspect. It is still heavily hinged on phenotypic methods for accurate identification and classification. Clinical microbiology involves the study of different characteristics of pathogens or mechanisms involving growth and infection and their various modes of transmission. This discipline was able to differentiate four different kinds of microorganisms causing infectious diseases, namely fungi, viruses, bacteria, and parasites. Using the knowledge acquired from clinical microbiology, doctors and physicians are able to devise treatments and cures of numerous diseases, help to identify potential health risks at a large extent, and learn the evolution if required of certain disorders.
The rapid development of the clinical microbiology market can be attributed to the wide R&D activities as well as rising cases of acute and chronic illness across the globe. According to the Centers for Disease Control and Prevention (CDC), there are over 10,000 cases for Tuberculosis, 55,000 cases of salmonella, 600 cases for meningococcal disease, and 36,000 cases for Lyme disease prevailed in the US alone in 2018.
Market Trends, Drivers, Restraints, and Opportunities
- Rising prevalence of acute illness and chronic diseases along with the rising cases of viral infection globally are key drivers for the market growth.
- Rapid expansion of hospitals and healthcare centers to advance medical facilities related to clinical microbiology to learn and analysis of several diseases are key factors boosting the market expansion.
- Favorable regulations from several governments and administrative bodies to promote clinical microbiology diagnostics are expected to propel the market growth.
- The COVID-19 pandemic has accelerated the growth of the global clinical microbiology market. Scientists and researchers of microbiology are working towards finding a vaccine to prevent and curb the spread of the virus. This is expected to spur the market growth.
- Shortage of skilled and trained professionals in handling the microbiological laboratories, which involve intercepting and processing specimens and samples. This is a key challenge that can hinder the growth on the global clinical microbiology market in the coming years.
- Limited training programs and a smaller number of professionals graduated from microbiology as a discipline especially in developing regions. This acts as a major restraining factor that can hamper the market expansion.
Scope of the Report
The report on the global clinical microbiology market size includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes
|
Details
|
Report Title
|
Clinical Microbiology Market Size - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
Base Year
|
2020
|
Historic Data
|
2018–2019
|
Forecast Period
|
2021–2028
|
Segmentation
|
Products (Laboratory Instruments [Incubators, Gram Stainers, Bacterial Colony Counters, Autoclave Sterilizers, Petri Dish Fillers, and Automated Culture Systems], Microbiology Analyzers [Molecular Diagnostic Instruments, Microscopes, and Mass Spectrometers], and Reagents), and Applications (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others)
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast
|
Key Players Covered in the Report
|
bioMerieux S.A; Cepheid Inc.; Danaher Corporation; Bruker Corporation; Becton Dickinson & Company; Hologic Inc.; Roche Diagnostics; and Alere Inc.
|
Global Clinical Microbiology Market Size Segment Insights
Reagents segment to account for a large market share
On the basis of products, the global clinical microbiology market size is segmented into laboratory instruments, microbiology analyzers, and reagents. The laboratory instruments segment is further segmented into incubators, gram stainers, bacterial colony counters, autoclave sterilizers, petri dish fillers, and automated culture systems. The microbiology analyzers segment is sub-divided into molecular diagnostic instruments, microscopes, and mass spectrometers. The reagents segment held a large revenue share of 60% of the global market owing to wide adoption of reagent products as primers, kits, solutions, and master mixes that are used for various diagnostic assays. This segment growth is also due to increasing investments and funding in their research and development activities with respect to their therapeutic and analytical projects.
Respiratory diseases segment to dominate the market
Based on applications, the market is divided into respiratory diseases, bloodstream infections, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and other diseases. The respiratory diseases segment is expected to dominate the market in the coming years. The segment growth is attributed to the rising levels of air pollution along with the increasing industrialization, which resulted in the sudden escalation in the occurrence of respiratory diseases. The respiratory diseases normally carry pathogens, which are contagious in nature that can spread rapidly.
North America to register a high CAGR
In terms of regions, the global clinical microbiology market is classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America represented a large share in the global clinical microbiology market in 2002 and is projected to register a high CAGR during the forecast period. The regional market growth is accredited to the fact that there is high development in the healthcare sector and wide adoption of advanced technology besides the rapid growth of several industries. Meanwhile, the market in Asia Pacific is expecting to grow at a fast rate during the forecast period 2021-2028. Japan is currently one of the top countries that allows massive development for solid technology in microbial testing.
Segments
Segments covered in the report
The global clinical microbiology market size has been segmented in terms of
Products
- Laboratory Instruments
- Incubators
- Gram Stainers
- Bacterial Colony Counters
- Autoclave Sterilizers
- Petri Dish Fillers
- Automated Culture Systems
- Microbiology Analyzers
- Molecular Diagnostic Instruments
- Microscopes
- Mass Spectrometers
- Reagents
Applications
- Respiratory Diseases
- Bloodstream Infections
- Gastrointestinal Diseases
- Sexually Transmitted Diseases
- Urinary Tract Infections
- Periodontal Diseases
- Others
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- bioMerieux S.A
- Cepheid Inc.
- Danaher Corporation
- Bruker Corporation
- Becton Dickinson & Company
- Hologic Inc.
- Roche Diagnostics
- Alere Inc.
Competitive Landscape
Some of the major players in the global clinical microbiology market are bioMerieux S.A; Cepheid Inc.; Danaher Corporation; Bruker Corporation; Becton Dickinson & Company; Hologic Inc.; Roche Diagnostics; and Alere Inc. Most of these players are currently engaged in strategic initiatives including mergers & acquisitions, promoting awareness, and new product development that can help them to formulate innovative designs and automated systems for the study for clinical microbiology.